HIMS
Hims & Hers Health, Inc.
There isn't enough reported data to score HIMS yet.
HYPD
Hyperion DeFi, Inc.
There isn't enough reported data to score HYPD yet.
HIMS Fundamentals
| Metric | Status |
|---|---|
| Strong | |
| Weak | |
| Stable | |
| Strong |
HIMS's revenue and balance sheet are currently strong, and its cash flow is stable, but its profitability is weak.
HYPD Fundamentals
| Metric | Status |
|---|---|
| Strong | |
| Stable | |
| Unavailable | |
| Unavailable |
HYPD's revenue is currently strong, and its profitability is stable. There isn't enough data to rate its cash flow and balance sheet.
HIMS PE Valuation
HIMS has no meaningful PE right now: it lost money over the past year.
HYPD PE Valuation
HYPD has no meaningful PE right now: it lost money over the past year.
HIMS Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Turning to a loss | |
| Strong growth | |
| Stable | |
| Limited | |
| Low |
Analysts expect HIMS's revenue to grow, but its earnings to decline. However, they disagree widely on these estimates.
HYPD Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Decline | |
| Strong growth | |
| -- | |
| Limited | |
| Low |
Analysts expect HYPD's revenue to grow, but its earnings to decline. However, they disagree widely on these estimates.
HIMS Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | -$0.83 | -257% |
| Q2 2026 | -$0.63 | -180% |
| Q1 2026 | -$0.09 | -113% |
| Q4 2025 | $0.51 | -3.8% |
| Q3 2025 | $0.53 | +20% |
| Q2 2025 | $0.79 | +888% |
| Q1 2025 | $0.68 | +$0.69 |
| Q4 2024 | $0.53 | +$0.64 |
HYPD has the stronger earnings trend. Trailing diluted EPS is down 257% for HIMS versus HYPD down 157%.
HYPD Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $3.78 | — |
| Q2 2025 | -$35.84 | +$27.36 |
| Q1 2025 | -$50.14 | +$9.06 |
| Q4 2024 | -$66.95 | -$14.15 |
| Q3 2024 | -$57.60 | -$5.60 |
| Q2 2024 | -$63.20 | -$8.80 |
| Q1 2024 | -$59.20 | $0.00 |
| Q4 2023 | -$52.80 | +$13.60 |
| Q3 2023 | -$52.00 | -$8.00 |
HYPD is still losing money, but far less than before: $35.84 per share over the past year, against $147.20 at its worst in late 2019.
HIMS Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $890.4M | +49% |
| Q2 2026 | $753.2M | +38% |
| Q1 2026 | $608.1M | +3.8% |
| Q4 2025 | $617.8M | +28% |
| Q3 2025 | $599M | +49% |
| Q2 2025 | $544.8M | +73% |
| Q1 2025 | $586M | +111% |
| Q4 2024 | $481.1M | +95% |
HIMS has the edge over HYPD on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -7.4% | -9.4 points |
| Q2 2026 | -13% | -18 points |
| Q1 2026 | -13% | -23 points |
| Q4 2025 | 1.5% | -2.4 points |
| Q3 2025 | 2% | -3.6 points |
| Q2 2025 | 4.9% | +1.4 points |
| Q1 2025 | 9.9% | +6.3 points |
| Q4 2024 | 3.9% | +4 points |
HIMS's operating margin was −7.4% last quarter, down 9.4 points from the same quarter a year ago.
HYPD Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q1 2026 | $244.3K | +1559% |
| Q4 2025 | $496.2K | +1666% |
| Q3 2025 | $302.5K | +18516% |
| Q1 2025 | $14.7K | +195% |
| Q4 2024 | $28.1K | +985% |
| Q3 2024 | $1.6K | +36% |
HYPD's revenue has grown year over year for four quarters in a row: $357,693 last quarter.
| Quarter | Margin | YoY |
|---|---|---|
| Q2 2026 | 8669% | N/A |
| Q1 2026 | 3575% | +24164 points |
| Q4 2025 | -8013% | +61225 points |
| Q3 2025 | 1464% | +452659 points |
| Q1 2025 | -20589% | +185035 points |
| Q4 2024 | -69238% | +219157 points |
| Q3 2024 | -451196% | +93060 points |
| Q2 2024 | -51661% | N/A |
HYPD has the edge over HIMS on profitability, with a higher operating margin.
HIMS Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $26M | -67% |
| Q2 2026 | -$68.2M | +$1.3M |
| Q1 2026 | $53.1M | +5.9% |
| Q3 2025 | $79.3M | -7% |
| Q2 2025 | -$69.5M | -230% |
| Q1 2025 | $50.1M | +94% |
| Q3 2024 | $85.3M | +238% |
| Q2 2024 | $53.6M | +219% |
HYPD has the stronger cash trend. Its trailing FCF is down 12% versus its history, compared with HIMS at down 84%.
HYPD Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q4 2024 | -$6.1M | +$356.5K |
| Q3 2024 | -$5.9M | +$475.6K |
| Q2 2024 | -$8.2M | -$2.3M |
| Q1 2024 | -$10M | -$2.1M |
| Q4 2023 | -$6.5M | -$1M |
| Q3 2023 | -$6.4M | +$624K |
| Q2 2023 | -$5.9M | -$1.1M |
| Q1 2023 | -$7.9M | +$479.4K |
HYPD has burned cash in almost every quarter: −$24M over the past year, against −$29M the year before.
HIMS Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.9% | +2.1M shares |
| 1 year | -6% | -14.9M shares |
| 3 years | +11% | +23.7M shares |
| 5 years | +17% | +33.8M shares |
HIMS has the edge over HYPD on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q4 2025 | $80.5M |
| Q3 2025 | $9.5M |
| Q2 2025 | — |
| Q1 2025 | — |
| Q4 2024 | $5M |
| Q3 2024 | $30M |
| Q2 2024 | $19.9M |
| Q1 2024 | $28.1M |
HYPD Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +61% | +1.3M shares |
| 1 year | +430% | +2.9M shares |
| 3 years | +737% | +3.1M shares |
| 5 years | +1320% | +3.3M shares |
HYPD has 4M diluted shares, up 430% from a year ago.
HIMS Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q1 2026 | -5.9x | Net Cash |
| Q4 2025 | -1.4x | Net Cash |
| Q3 2025 | -2.2x | Net Cash |
| Q2 2025 | -7.3x | Net Cash |
| Q1 2025 | -2.1x | Net Cash |
| Q4 2024 | -2.8x | Net Cash |
| Q3 2024 | -2.9x | Net Cash |
| Q2 2024 | -5.5x | Net Cash |
HIMS has more cash than debt.
HYPD Net Leverage
HYPD's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
HIMS Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 36.0 | Neutral |
| Stochastic | 23.0 | Neutral |
HIMS's weekly RSI is 36 (neutral) and its Stochastic is 23 (neutral).
HYPD Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 43.4 | Neutral |
| Stochastic | 25.1 | Neutral |
HYPD's weekly RSI is 43 (neutral) and its Stochastic is 25 (neutral).
HIMS PE vs Healthcare Sector
| Metric | HIMS | Sector median | Relative |
|---|---|---|---|
| PE | N/A | 26x | — |
HIMS has no meaningful PE right now: it lost money over the past year.
HYPD PE vs Healthcare Sector
HYPD has no meaningful PE right now: it lost money over the past year.
HIMS Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $27.3 | 28% below |
| 20 week MA | $29.2 | 32% below |
| 50 week MA | $27.7 | 29% below |
| 100 week MA | $35.9 | 45% below |
| 200 week MA | $24.4 | 19% below |
HIMS is in a downtrend: it's below all five of its weekly moving averages, and 19% below its 200-week average.
HYPD Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $3.16 | 14% below |
| 20 week MA | $3.09 | 12% below |
| 50 week MA | $3.34 | 19% below |
| 100 week MA | $4.42 | 38% below |
| 200 week MA | $68.7 | 96% below |
HYPD is in a downtrend: it's below all five of its weekly moving averages, and 96% below its 200-week average.
HIMS Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $9.89 | $15.0 | +51% |
| 2021 | $15.0 | $6.65 | -56% |
| 2022 | $6.65 | $6.43 | -3.3% |
| 2023 | $6.43 | $8.90 | +38% |
| 2024 | $8.90 | $26.6 | +198% |
| 2025 | $26.6 | $34.3 | +29% |
| 2026 YTD | $34.3 | $19.7 | -42% |
HIMS's yearly returns have swung widely, from +198% in 2024 to −56% in 2021. It's down 42% so far in 2026.
HYPD Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $305.6 | $455.2 | +49% |
| 2021 | $455.2 | $329.6 | -28% |
| 2022 | $329.6 | $128.8 | -61% |
| 2023 | $128.8 | $166.4 | +29% |
| 2024 | $166.4 | $7.52 | -95% |
| 2025 | $7.52 | $3.84 | -49% |
| 2026 YTD | $3.84 | $2.72 | -29% |
HYPD has the edge over HIMS on returns for 2026, with the stronger performance.